HBsAg-Negative, Anti-HBc–Negative Patients Still Have a Risk of Hepatitis B Virus–Related Hepatitis after Autologous Stem Cell Transplantation for Multiple Myeloma or Malignant Lymphoma-Reference-Cited by-同舟云学术

HBsAg-Negative, Anti-HBc–Negative Patients Still Have a Risk of Hepatitis B Virus–Related Hepatitis after Autologous Stem Cell Transplantation for Multiple Myeloma or Malignant Lymphoma

Published:2018-10-15 Issue:4 Volume:50 Page:1121-1129
ISSN:1598-2998
Container-title:Cancer Research and Treatment
language:en
Short-container-title:Cancer Res Treat

Author:

Park Hyunsung,Kim Do Young,Kim Soo-Jeong,Chung Haerim,Cho Hyunsoo,Jang Ji Eun,Cheong June-Won,Min Yoo Hong,Song Jae-Woo,Kim Jin Seok

Publisher

Korean Cancer Association

Subject

Cancer Research,Oncology

Link

http://e-crt.org/upload/pdf/crt-2017-329.pdf

Reference23 articles.

1. Risk and prophylaxis strategy of hepatitis B virus reactivation in patients with lymphoma undergoing chemotherapy with or without rituximab

2. Management of patients with hepatitis B who require immunosuppressive therapy

3. Chronic hepatitis B: Update 2009

4. HBV reactivation in a HBsAg-negative patient with multiple myeloma treated with prednisolone maintenance therapy after autologous HSCT

5. Reactivation of hepatitis B virus in HBsAg-negative patients with multiple myeloma: two case reports

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Seroreversion of hepatitis B surface antigen among subjects with resolved hepatitis B virus infection: A community‐based cohort study;Journal of Gastroenterology and Hepatology;2021-08-08

2. Overlooked prophylaxis of Hepatitis B in patients undergoing hematopoietic stem cell transplantation;Erciyes Medical Journal;2020

3. Seronegative occult HBV reactivation complicated with fulminant acute liver failure after rituximab for chronic inflammatory demyelinating polyneuropathy;Infectious Diseases;2019-11-26